Ehrentraud Eichelbaum, MD
General Practice · Bushnell, FLNPI 1255518486
Payments from drug & device makers
Across 187 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$702
- GSK$573
- Novartis$308
- AbbVie$265
- Bayer$228
- Esperion Therapeutics, Inc.$183
- plus $1K from 27 others
What the payments were for
- Speaking & faculty fees$221%
- Food & beverage$3,44599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 39 | $702 |
| GSK | 30 | $573 |
| Novartis | 17 | $308 |
| AbbVie | 14 | $265 |
| Bayer | 10 | $228 |
| Esperion Therapeutics, Inc. | 8 | $183 |
| Novo Nordisk | 11 | $165 |
| Pfizer | 8 | $162 |
| Johnson & Johnson(2 entities) | 8 | $161 |
| Lilly USA, LLC | 11 | $131 |
| Sunovion Pharmaceuticals Inc. | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| Greenwich Biosciences, Inc. | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Acorda Therapeutics, Inc | 1 | $22 |
| Amgen | 1 | $21 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Biogen | 1 | $14 |
| Abbott | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
How this compares
$3,467 in reported general payments places this provider in the 90th percentile of 6,901 general practice providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other general practice in Bushnell
- Jose CardonaMiami$71M
- Lawrence GalitzMiami Gardens$42.5M
- Armando AcevedoMiami$15.2M
- Jorge AmayaMiami$14.2M
- Frank AlvarezHialeah$13.6M
- Hector RodriguezMiami$12.8M
- Eddie ArmasSouth Miami$12.4M
- Idalia AcostaMiami$11.4M
- Lilia Rodriguez AblesMiami$10.7M
- Jorge Monroy AvellaOcoee$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.